Latest Treatment Guidelines On Achalasia Management & Diagnosis As Per “The American Journal Of Gastroenterology”!

In August issue of The American Journal of Gastroenterology the latest guidelines for Achalasia management and diagnosis were issued to make things easier for the victims of this disorder. For your reference we are providing you the article for read. The source of this article as stated earlier is “The American Journal of Gastroenterology”

It states that “Achalasia is an incurable disease characterized by incomplete or absent relaxation of the LES and aperistalsis of the esophageal body. The symptomatic consequence of this motility disorder is the classic presentation of dysphagia to solids and liquids associated with regurgitation of bland undigested food or saliva.”
They claim that “Surgical mytomy has shown excellent results in most patients and remains the surgery of choice, with more being done laparoscopically. The benefit of adding a fundoplication was demonstrated in a double-blind randomized trial comparing myotomy with versus without fundoplication. In this study, abnormal acid exposure on pH monitoring was found in 47 percent of patients without an antireflux procedure and 9 percent in patients that had a posterior Dor fundoplication.” Dr. Vaezi also mentioned that “A subsequent cost-utility analysis based on the results of this trial found that myotomy plus Dor fundoplication was more cost effective than myotomy alone because of the costs of treating GERD.”
They also claim that “We used the best available evidence and expert opinion to objectively measure our results. The GRADE system was used to measure the quality of evidence and the strength of recommendations.”
For any detailed information you can also search online on

https://www.nature.com/ajg/index.html

and get the latest news published by the journal team every now and then. We will try our best to keep you posted with any latest research from time to time here in this space.
So, stay tuned for more.